<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Chem</journal-id><journal-id journal-id-type="iso-abbrev">BMC Chem</journal-id><journal-title-group><journal-title>BMC Chemistry</journal-title></journal-title-group><issn pub-type="epub">2661-801X</issn><publisher><publisher-name>Springer International Publishing</publisher-name><publisher-loc>Cham</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40399971</article-id><article-id pub-id-type="pmc">PMC12093686</article-id><article-id pub-id-type="publisher-id">1500</article-id><article-id pub-id-type="doi">10.1186/s13065-025-01500-7</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Green chromatographic approach to determine methocarbamol, aspirin and their related impurities in their combined pharmaceutical formulation and human plasma: with computational evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Bassuoni</surname><given-names>Yasmine F.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>AboulMagd</surname><given-names>Asmaa M.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Ibrahim</surname><given-names>Maha M.</given-names></name><address><email>Maha_habiba2012@hotmail.com</email><email>Maha.Mahmoud@pharm.mti.edu.eg</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00746ch50</institution-id><institution-id institution-id-type="GRID">grid.440876.9</institution-id><institution-id institution-id-type="ISNI">0000 0004 0377 3957</institution-id><institution>Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, </institution><institution>Modern University for Technology and Information (MTI), </institution></institution-wrap>12582 Al Hadaba Al Wosta, Cairo, Egypt </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05s29c959</institution-id><institution-id institution-id-type="GRID">grid.442628.e</institution-id><institution-id institution-id-type="ISNI">0000 0004 0547 6200</institution-id><institution>Pharmaceutical Chemistry Department, Faculty of Pharmacy, </institution><institution>Nahda University in Beni-Suef (NUB), </institution></institution-wrap>Beni-Suef, 62513 Egypt </aff></contrib-group><pub-date pub-type="epub"><day>21</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>21</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2025</year></pub-date><volume>19</volume><issue>1</issue><elocation-id>136</elocation-id><history><date date-type="received"><day>27</day><month>2</month><year>2025</year></date><date date-type="accepted"><day>6</day><month>5</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">Nowadays, one of the main objectives is to protect the environment and reduce the adverse impacts of chemicals on it. One of the most difficult issues for researchers is determining the efficiency and quality of the suggested approach in terms of environmental and human safety. The present research presents advanced, accurate, green high-performance liquid chromatographic method (HPLC) to estimate a combination of methocarbamol (MET) and aspirin (ASP) as well as their related impurities, guaifenesin (GUF) and salicylic acid (SA), respectively, with low retention time and ideal separation. Chromatographic separation was performed on X-Bridge C<sub>8</sub> reversed phase (RP) column (4.6&#x02009;&#x000d7;&#x02009;250&#x000a0;mm, 5&#x000a0;&#x003bc;m particle size) utilizing methanol: water: triethylamine (70:30, 0.1% by volume) at pH 3.00 by o-phosphoric acid as a mobile phase with 2.00&#x000a0;mL&#x000a0;min<sup>&#x02212;1</sup> flow rate at 254.00&#x000a0;nm. The proposed method succeeded to achieve linearity over a concentration ranges of 0.30&#x02013;50.00&#x000a0;&#x003bc;g&#x000a0;mL<sup>&#x02212;1</sup>, 1.00&#x02013;300.00&#x000a0;&#x003bc;g&#x000a0;mL<sup>&#x02212;1</sup>, 10.00&#x02013;500.00&#x000a0;&#x003bc;g&#x000a0;mL<sup>&#x02212;1</sup> and 0.10&#x02013;50.00&#x000a0;&#x003bc;g&#x000a0;mL<sup>&#x02212;1</sup> for GUF, MET, ASP and SA, respectively. All the developed results were validated in compliance with the International Council of Harmonization (ICH) instructions. The suggested method was successfully applied to assess MET and ASP in their pharmaceutical formulation and in spiked human plasma. The molecular docking approach was employed to evaluate how the two drugs and their related impurities interacted with the stationary phase and to predict the suggested sequence of elution. The greenness of the developed analytical method was evaluated using whiteness assessment and two green approaches; analytical eco-scale and AGREE. The proposed method proved not only to be green, time-saving and more sensitive for the routine analysis of MET and ASP in QC laboratories, but also it can effectively handle the presence of impurities such as GUF and SA.</p><sec><title>Graphical Abstract</title><p id="Par2">
<graphic position="anchor" xlink:href="13065_2025_1500_Figa_HTML" id="MO1"/></p></sec><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1186/s13065-025-01500-7.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Methocarbamol</kwd><kwd>Aspirin</kwd><kwd>Guaifenesin</kwd><kwd>Salicylic acid</kwd><kwd>HPLC</kwd><kwd>Green analytical approach</kwd><kwd>Whiteness assessment</kwd></kwd-group><funding-group><award-group><funding-source><institution>Modern Academy for Technology, Computer Science &#x00026; Management</institution></funding-source></award-group><open-access><p>Open access funding provided by The Science, Technology &#x00026; Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB).</p></open-access></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer Nature Switzerland AG 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par3">Analysis of impurities in the pharmaceutical field is one of the most crucial steps to guarantee their safety, effectiveness and quality [<xref ref-type="bibr" rid="CR1">1</xref>]. Impurities may result from different sources, including products decomposition and manufacturing procedures [<xref ref-type="bibr" rid="CR2">2</xref>]. As consequence, the development of an eco-friendly analytical procedures to determine the pharmaceutical dosage form in the presence of its impurities is regarded important [<xref ref-type="bibr" rid="CR3">3</xref>].</p><p id="Par4">HPLC is an extensive and recommended method used for drug analysis at several stages, covering manufacturing and confirming the quality of pharmaceutical dosage formulations [<xref ref-type="bibr" rid="CR4">4</xref>]. Researchers become more interested in developing environmentally friendly analytical procedures to reduce environmental ecological impact and improve analyst safety and health conditions. Two different approaches were suggested to assess the established method environmentally, White Analytical Chemistry (WAC) and Green Analytical Chemistry (GAC) [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. In addition to the green factors, WAC considers two other major factors when estimating the method's quality. The additional two factors are the practical (blue) and analytical (red) aspects [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>].</p><p id="Par5">One of the most important computational tools to understand and detect the physical foundation of the structure of compounds is the molecular docking technique through studying the system's dynamic growth, which confirms the practical work output. Predicting the elution sequence and estimating the analytes&#x02019; interaction with the stationary phase were the primary objectives of the molecular docking technique, which is used nowadays in chromatographic methodology [<xref ref-type="bibr" rid="CR9">9</xref>]. The results of the suggested method were then verified by identifying which drug would be more and less retained on the stationary phase [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>].</p><p id="Par6">The presence of related impurities may reduce the therapeutic efficacy of their drugs and decrease their stability besides producing undesirable adverse effects. So maximum permitted limits for drug-related impurities have been specified by a number of pharmacopoeias [<xref ref-type="bibr" rid="CR12">12</xref>]. Additionally, the main clinical application for GUF usually includes expectorant usage. Concerning the analgesic potency of SA, it is five times less than ASP because ASP suppresses the biosynthesis of prostaglandins through acetylation of the cyclo-oxygenase enzyme [<xref ref-type="bibr" rid="CR13">13</xref>]. The levels of GUA and SA should not be higher than 1% and 3% for MET and ASP respectively, according to the USP [<xref ref-type="bibr" rid="CR14">14</xref>].</p><p id="Par7">MET (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>A) is a 3-2-methoxyphenoxy-1,2-propanediol 1-carbamate. It acts as a muscle relaxant to relief skeletal muscle spasms [<xref ref-type="bibr" rid="CR15">15</xref>]. Various analytical techniques have been published to quantify methocarbamol individually or in the presence of other drugs, including spectrofluorimetric method [<xref ref-type="bibr" rid="CR16">16</xref>], electrochemical method [<xref ref-type="bibr" rid="CR17">17</xref>], spectrophotometric method [<xref ref-type="bibr" rid="CR18">18</xref>], chromatographic methods [<xref ref-type="bibr" rid="CR19">19</xref>&#x02013;<xref ref-type="bibr" rid="CR22">22</xref>] and TLC-densitometric method [<xref ref-type="bibr" rid="CR23">23</xref>].<fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p><bold>A</bold> Methocarbamol. <bold>B</bold> Aspirin. <bold>C</bold> Guaifenesin. <bold>D</bold> Salicylic Acid</p></caption><graphic xlink:href="13065_2025_1500_Fig1_HTML" id="MO2"/></fig></p><p id="Par8">ASP (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>B) is a 2-Acetyloxy benzoic acid. It acts as analgesic and antipyretic [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. MET is commonly co-formulated or co-administered with analgesics such as ASP, paracetamol, diclofenac and ibuprofen in order to relieve muscle spasms [<xref ref-type="bibr" rid="CR26">26</xref>]. GUF and SA (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>C and D) are reported as impurities through United State pharmacopeia (USP) for MET and ASP, respectively [<xref ref-type="bibr" rid="CR14">14</xref>]. In addition, GUA and SA are considered to be starting materials in MET and ASP synthesis, respectively, however being as byproducts of their hydrolysis.</p><p id="Par9">The combination of MET and ASP in pharmaceutical dosage form has been utilized as skeletal muscle relaxants and confirmed to be highly effective therapeutic medications to treat muscular spasms, as well as for use as surgical anesthetics. The increasing prevalence of skeletal muscle relaxants in medicine triggered the application of a simple, precise, accurate, sensitive method for analyzing the concentration in pure form and pharmaceutical dosage formulation [<xref ref-type="bibr" rid="CR26">26</xref>].</p><p id="Par10">Several techniques were reported through USP to determine MET and ASP individually such as spectrophotometric, chromatographic and titrimetric methods [<xref ref-type="bibr" rid="CR14">14</xref>]. Few analytical techniques have been covered in literatures to determine MET and ASP such as chromatographic [<xref ref-type="bibr" rid="CR27">27</xref>] and spectrophotometric methods [<xref ref-type="bibr" rid="CR28">28</xref>]. Currently only one HPLC method has been published for the simultaneous estimation of MET, ASP and their related impurities [<xref ref-type="bibr" rid="CR29">29</xref>].</p><p id="Par11">Different approaches were utilized to assess the greenness of procedures, including the Analytical Eco-Scale [<xref ref-type="bibr" rid="CR30">30</xref>] and AGREE [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR32">32</xref>]. Furthermore, our main objective in the present research was to perform a green, advanced and sensitive HPLC method with low retention times to separate the four intended compounds in one chromatographic run not only in pure powder form but also in spiked human plasma to provide a significant improvement and primary advantage above the only one reported approach [<xref ref-type="bibr" rid="CR29">29</xref>]. In addition to molecular docking was implemented to investigate the elution performance of the four intended compounds, as well as their interactions with the stationary phase. Furthermore, the greenness and whiteness profiles of developed method were evaluated.</p></sec><sec id="Sec2"><title>Experimental</title><sec id="Sec3"><title>Apparatus</title><p id="Par12">Dionex Ultimate 3000 HPLC device, provided with a diode array detector and an autosampler for injection. The device is complemented by a tetra solvent delivery pump (Massachusetts, USA). The chromatographic separation was achieved using X-Bridge C<sub>8</sub> reversed phase (RP) column (4.6&#x02009;&#x000d7;&#x02009;250&#x000a0;mm, 5&#x000a0;&#x003bc;m particle size).</p></sec><sec id="Sec4"><title>Software</title><p id="Par13">Molecular docking studies were performed using Molecular Operating Environment 2024.02 (Chemical Computing Group, Montreal, QC, Canada).</p></sec><sec id="Sec5"><title>Chemicals and solvents</title><sec id="Sec6"><title>Standards and reagents</title><p id="Par14">Standards of MET, ASP, GUF and SA were provided from (Sigma-Aldrich Co, Germany) with purities of about 99.66%, 99.85%, 99.55% and 99.32%, respectively. Methanol of HPLC grade was purchased (Fisher Co., Germany). De-ionized water was utilized. Human plasma was obtained from the blood bank, VACSERA (Holding Company for Biological Products and Vaccines), Egypt.</p></sec><sec id="Sec7"><title>Pharmaceutical formulation</title><p id="Par15">Robaxisal extra strength&#x000ae; coated tablets were acquired from GlaxoSmithKline Consumer HealthCare ULC (GSK) company, Canada. Tablets claimed to contain 400.00&#x000a0;mg MET and 500.00&#x000a0;mg ASP as active ingredients (Batch No. PAA168448).</p></sec><sec id="Sec8"><title>Stock and working solutions</title><p id="Par16">Weights corresponding to 10.00&#x000a0;mg of GUF, MET, ASP, and SA were individually transferred into four separate 10&#x000a0;mL volumetric flasks. The volume in each flask was then adjusted with methanol to achieve final stock solutions of 1.00&#x000a0;mg&#x000a0;mL<sup>&#x02212;1</sup> for each drug. Subsequently, working solutions for the studied drugs were prepared freshly through appropriate dilution of the previously prepared stock solutions<bold>.</bold></p></sec></sec></sec><sec id="Sec9"><title>Procedures</title><sec id="Sec10"><title>Chromatographic conditions</title><p id="Par17">The adequate separating conditions were achieved using X-Bridge C<sub>8</sub> RP column (4.6&#x02009;&#x000d7;&#x02009;250&#x000a0;mm, 5&#x000a0;&#x003bc;m particle size). Optimum separation was achieved utilizing methanol: water: triethylamine (70: 30, 0.1% by volume) at pH 3.00 adjusted by o-phosphoric acid as a mobile phase with flow rate of 2.00&#x000a0;mL&#x000a0;min<sup>&#x02212;1</sup> and UV detection at 254.00 nm.</p></sec><sec id="Sec11"><title>Construction of calibration curves</title><p id="Par18">Concentration ranges of 0.30&#x02013;50.00&#x000a0;&#x003bc;g&#x000a0;mL<sup>&#x02212;1</sup>, 1.00&#x02013;300.00&#x000a0;&#x003bc;g&#x000a0;mL<sup>&#x02212;1</sup>, 10.00&#x02013;500.00&#x000a0;&#x003bc;g&#x000a0;mL<sup>&#x02212;1</sup> and 0.10&#x02013;50.00&#x000a0;&#x003bc;g&#x000a0;mL<sup>&#x02212;1</sup> for GUF, MET, ASP and SA, respectively were established by transferring aliquots from their stock solutions (1.00&#x000a0;mg&#x000a0;mL<sup>&#x02212;1</sup>) into four distinct sets of 50 mL volumetric flasks, which were then completing the volume with methanol. The chromatograms were then recorded and the peak areas for each drug were computed and recorded. Calibration curves were constructed with the corresponding concentrations of each drug and the regression equations were then recorded and computed.</p></sec><sec id="Sec12"><title>Application of laboratory prepared mixtures</title><p id="Par19">Several mixtures containing different ratios of MET, ASP and their related impurities were prepared using their respective stock solutions. The prepared solutions were then analyzed using the previously mentioned chromatographic conditions. The concentrations were calculated from the corresponding regression equations for each drug.</p></sec><sec id="Sec13"><title>Application to pharmaceutical formulation and standard addition technique</title><p id="Par20">Ten tablets of Robaxisal extra strength&#x000ae; tablet containing MET and ASP were weighed and finely powdered then the average weight of one tablet was calculated. One tablet contains amount equivalent to 400.00 mg and 500.00 mg of MET and ASP, respectively was weighted then transferred into two separate 100&#x000a0;mL volumetric flasks, dissolved in 70&#x000a0;mL of methanol, and sonicated well for 30 min then the volume was completed to the mark. The prepared solutions were then diluted to obtain final concentrations equivalent to 100.00 and 125.00&#x000a0;&#x003bc;g&#x000a0;mL<sup>&#x02212;1</sup> of MET and ASP, respectively. Then the standard addition approach was applied by adding three known concentrations of the standards of each drug. The added concentrations were selected to be approximately lower, equal and higher than the previously prepared dosage form concentrations.</p></sec><sec id="Sec14"><title>Application to spiked human plasma</title><p id="Par21">In two separate 10&#x000a0;mL volumetric flasks, one milliliter of human plasma was added and spiked with a known amount of MET and ASP standards, then the volume was competed using methanol. The area under the curve was recorded and the concentrations of the studied drugs were determined from the corresponding regression equations.</p></sec><sec id="Sec15"><title>Molecular docking studies</title><p id="Par22">To rationalize our experimental results, a molecular docking study for methocarbamol (MET) and aspirin (ASP) as well as their related impurities; guaifenesin (GUF) and salicylic acid (SA) with X-Bridge C<sub>8</sub> reversed phase (RP) column was performed using Molecular Operating Environment 2024.02 (Chemical Computing Group, Montreal, QC, Canada). The structures of C<sub>8</sub> were built by MOE Builder function. MOE Quick Prep protocol was used to add hydrogen and minimize the structure. The 2 drugs and their impurities were drawn by Chem Bio Draw Ultra Ver.14 Suite (PerkinElmer, Waltham, MA, USA); its potential energy was diminished applying the proper force field AMBER 10 (University of California, San Francisco, CA, USA). The default docking protocol implemented in MOE was applied. Conformations of ligand were fitted in the position with the Triangle Matcher method and ordered with the London &#x00394;G scoring function. The produced poses were ranked as per their docking scores. Finally, the best position in each case according to the docking score was chosen.</p></sec><sec id="Sec16"><title>Method validation</title><p id="Par23">Validation of the developed chromatographic method was performed according to the ICH guidelines [<xref ref-type="bibr" rid="CR33">33</xref>]. The assessed parameters were linearity range, accuracy, precision, limit of detection (LOD), limit of quantification (LOQ) and robustness.</p></sec></sec><sec id="Sec17"><title>Results and discussion</title><p id="Par24">In the pharmaceutical analysis field HPLC technique is used extensively, but it generates a significant amount of organic toxic waste. In our research work we always give particular consideration to Green Analytical Chemistry (GAC) [<xref ref-type="bibr" rid="CR34">34</xref>] not only analysis of the pharmaceutical drugs. We focus especially on the methods and resources available to make sample preparation and analytical procedures more environmentally friendly. The substitution of toxic chemicals, technique miniaturization and automation, which enable significantly lower reagent consumption and waste generation are deemed to be the key tenets. These measures also help to minimize or eliminate the adverse impacts of analytical procedures [<xref ref-type="bibr" rid="CR5">5</xref>]. Our aim was to develop an eco-friendly, accurate and selective chromatographic method to determine the binary mixture of MET muscle relaxant and ASP in their combined pharmaceutical formulation and spiked human plasma besides in presence of their pharmacopeial related impurities GUF and SA. Our method can also be considered a stability indicating assay method (SIAM) [<xref ref-type="bibr" rid="CR35">35</xref>] as it enables determining MET and ASP as well as their related impurities and degradation products GUF and SA, respectively.</p><sec id="Sec18"><title>Method development and optimization:</title><p id="Par25">An extensive examination of key factors impacting the effectiveness of the RP-HPLC approach was carried out to assure the method's reliability and performance. A single factor was altered sequentially, while the remaining chromatographic parameters stayed unchanged. Furthermore, method optimization kept the greatest levels of sensitivity and resolution while cutting down on waste production by shortening the time required for chromatographic analysis. Many trials have been conducted on different types of columns to achieve the best possible separation, including X-Bridge C<sub>18</sub> RP column (4.6&#x02009;&#x000d7;&#x02009;250&#x000a0;mm, 5&#x000a0;&#x003bc;m particle size), Equisil C<sub>18</sub> (5&#x000a0;&#x003bc;m, 4.6&#x02009;&#x000d7;&#x02009;250&#x000a0;mm), Kromasil C<sub>18</sub> (4.6&#x02009;&#x000d7;&#x02009;150&#x000a0;mm, 5&#x000a0;&#x003bc;m particle size), Cortecs C<sub>18</sub> column (4.6&#x02009;&#x000d7;&#x02009;50&#x000a0;mm, 2.7&#x000a0;&#x003bc;m particle size) and Cortecs C<sub>8</sub> column (4.6&#x02009;&#x000d7;&#x02009;50&#x000a0;mm, 2.7&#x000a0;&#x003bc;m particle size). Best results were achieved using X-Bridge C<sub>8</sub> RP (4.6&#x02009;&#x000d7;&#x02009;250&#x000a0;mm, 5&#x000a0;&#x003bc;m particle size) column. Concerning the mobile phase, we took care to use safe and eco-friendly solvents as possible as we could, to minimize environmental risks during the technique development stage. Initially, mobile phases composed of methanol: water were tested with different ratios as (50: 50, v/v), (70: 30, v/v), (30: 70, v/v), (60: 40, v/v) at different pH ranges 3.00, 3.50 and 4.00 using o-phosphoric acid. Additionally, mobile phases composed of methanol: 0.1% formic acid (50: 50, v/v), (60: 40, v/v) and (80: 20, v/v) were tried. Moreover, we tried methanol: phosphate buffer at various pH ranges 3.00, 3.50 and 4.50 using o-phosphoric acid in the ratios (50: 50, v/v), (70: 30, v/v) and (30: 70, v/v). Regretfully, the four compounds could not be effectively separated by any of the previous mobile phases as overlapped peaks were obtained. We started to observe improved in the separation by using methanol: water: triethylamine (50: 50, 0.1% by volume), (60: 40, 0.1% by volume) and (70: 30, 0.1% by volume). Mobile phase consisted of methanol: water: triethylamine (70: 30, 0.1% by volume) adjusting pH to 3.00 by o-phosphoric acid produced the ideal resolved peaks. Particularly in terms of lowering the peak tailing, the findings have improved with the addition of trimethylamine [<xref ref-type="bibr" rid="CR36">36</xref>]. Additionally, many flow rates and UV detection wavelengths have been examined as 1.00, 1.50, 2.00- and 2.50&#x000a0;mL&#x000a0;min<sup>&#x02212;1</sup> and 210.00, 254.00 and 270.00&#x000a0;nm, respectively. Eventually, best conditions for optimum separation and acceptable system suitability parameters were achieved using X-Bridge C<sub>8</sub> RP (4.6&#x02009;&#x000d7;&#x02009;250&#x000a0;mm, 5&#x000a0;&#x003bc;m particle size) column, methanol: water: triethylamine (70: 30, 0.1% by volume) at pH 3.00 by o-phosphoric acid with 2.00&#x000a0;mL&#x000a0;min<sup>&#x02212;1</sup> flow rate and UV detection at 254.00&#x000a0;nm, as presented in Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>.<fig id="Fig2"><label>Fig.&#x000a0;2</label><caption><p>HPLC chromatogram of GUF, MET, ASP and SA</p></caption><graphic xlink:href="13065_2025_1500_Fig2_HTML" id="MO3"/></fig></p><p id="Par26">Several system suitability parameters were assessed to the separated peaks, including tailing factor, resolution, retention factor and separation factor. These measurements were then compared to the USP pharmacopeia acceptable reference values [<xref ref-type="bibr" rid="CR14">14</xref>]. Table <xref rid="Tab1" ref-type="table">1</xref> illustrates the comparison results, which support the developed method's compliance with the necessary system suitability criteria. The chromatographic method was optimized, leading to an improvement in the separation efficiency and the produced system suitability parameters to analyze GUF, MET, ASP and SA.<table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>System suitability parameters for the proposed HPLC method</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Parameters</th><th align="left">GUF</th><th align="left">MET</th><th align="left">ASP</th><th align="left">SA</th><th align="left">Acceptable values [<xref ref-type="bibr" rid="CR14">14</xref>]</th></tr></thead><tbody><tr><td align="left">Retention time (t<sub>R</sub>) (min)</td><td align="left">3.70</td><td align="left">4.20</td><td align="left">4.50</td><td align="left">6.5</td><td align="left">&#x02013;</td></tr><tr><td align="left">Resolution (R<sub>S</sub>)</td><td align="left" colspan="2">1.25</td><td align="left" colspan="2">2.22</td><td align="left">&#x02009;&#x0003e;&#x02009;1</td></tr><tr><td align="left">Separation Factor (&#x003b1;)</td><td align="left" colspan="2">1.20</td><td align="left" colspan="2">1.65</td><td align="left">&#x02009;&#x0003e;&#x02009;1</td></tr><tr><td align="left">Symmetry Factor (T)</td><td align="left">1</td><td align="left">1</td><td align="left">1</td><td align="left">1.08</td><td align="left">&#x02009;=&#x02009;1 for typical symmetric peak</td></tr><tr><td align="left">Retention Factor (K&#x002cb;)</td><td align="left">1.96</td><td align="left">2.36</td><td align="left">2.60</td><td align="left">4.20</td><td align="left">The higher the retention factor, the longer the retention time</td></tr><tr><td align="left">Column Efficiency (N)</td><td align="left">5476</td><td align="left">7056</td><td align="left">5184</td><td align="left">1600</td><td align="left">Increase efficiency of separation</td></tr><tr><td align="left">HETP<sup>*</sup></td><td align="left">4.57&#x02009;&#x000d7;&#x02009;10<sup>&#x02013;3</sup></td><td align="left">3.54&#x02009;&#x000d7;&#x02009;10<sup>&#x02013;3</sup></td><td align="left">4.82&#x02009;&#x000d7;&#x02009;10<sup>&#x02013;3</sup></td><td align="left">1.56&#x02009;&#x000d7;&#x02009;10<sup>&#x02013;2</sup></td><td align="left">The smaller the value the higher the column efficiency</td></tr></tbody></table><table-wrap-foot><p><sup>*</sup>Height equivalent to theoretical plate (cm/plate)</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec19"><title>Molecular docking studies</title><p id="Par27">In this work, the interactions between the drugs and the stationary phase were performed and the binding energies were determined using a reversed phase X-Bridge C<sub>8</sub> column Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>A, which only had an octa chain that could provide hydrophobic interactions. After simulating the same conditions for MET and its impurity component GUF, we thoroughly examined the resulting trajectories and discovered that both the drug and its impurity component interact with the stationary phase in multiple ways. Polarity affects how pharmaceuticals interact with the column; the least polar medication will be the one that is most retained with the stationary phase, while the most polar drug will be the one that is least retained with the stationary phase. It was discovered that MET forms a hydrophobic interaction, Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>B, However, as shown in Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>C, its impurity elutes first with a binding energy of &#x02212;&#x000a0;3.00&#x000a0;kcal/mol because it was found to be more polar than the drug in its intact form. Aspirin elutes with a binding energy of &#x02212;&#x000a0;3.13&#x000a0;kcal/mol because it exhibits less polarity, as seen in Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>D. It also served to validate the results of the suggested method.<fig id="Fig3"><label>Fig.&#x000a0;3</label><caption><p>Diagram presents: <bold>A</bold> Composition of X-Bridge C<sub>8</sub> reversed phase column, <bold>B</bold> 3D interaction of MET and the reversed phase stationary phase Si&#x02013;O showing hydrophobic interaction, <bold>C</bold> 3D interaction of GUF and the reversed phase stationary phase Si&#x02013;O showing hydrogen bond interaction, <bold>D</bold> 3D interaction of ASP and the reversed phase stationary phase Si&#x02013;O showing van der-waals interaction</p></caption><graphic xlink:href="13065_2025_1500_Fig3_HTML" id="MO4"/></fig></p></sec><sec id="Sec20"><title>Method validation</title><p id="Par28">In compliance with ICH recommendations [<xref ref-type="bibr" rid="CR33">33</xref>], the validation scheme was applied to the suggested HPLC method, which include linearity range, accuracy, precision, LOD and LOQ as well as robustness.</p><sec id="Sec21"><title>Range and linearity</title><p id="Par29">A linear relationship was established between the peak area and the corresponding concentration of each drug under the specific experimental conditions in the range of 0.30&#x02013;50.00&#x000a0;&#x003bc;g&#x000a0;mL<sup>&#x02212;1</sup>, 1.00&#x02013;300.00&#x000a0;&#x003bc;g&#x000a0;mL<sup>&#x02212;1</sup>, 10.00&#x02013;500.00&#x000a0;&#x003bc;g&#x000a0;mL<sup>&#x02212;1</sup> and 0.10&#x02013;50.00&#x000a0;&#x003bc;g&#x000a0;mL<sup>&#x02212;1</sup> for GUF, MET, ASP and SA, respectively. The results of the validation parameters of the proposed HPLC method were summarized in Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref><bold>.</bold><table-wrap id="Tab2"><label>Table&#x000a0;2</label><caption><p>Validation parameters of the proposed HPLC method to determine, MET, ASP GUF and SA in pure powder forms</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Parameters</th><th align="left">MET</th><th align="left">ASP</th><th align="left">GUF</th><th align="left">SA</th></tr></thead><tbody><tr><td align="left">Linearity</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#x000a0;Slope</td><td align="left">0.11</td><td align="left">0.12</td><td align="left">0.10</td><td align="left">1.03</td></tr><tr><td align="left">&#x000a0;Intercept</td><td align="left">0.20</td><td align="left">0.68</td><td align="left">0.09</td><td align="left">1.16</td></tr><tr><td align="left">&#x000a0;Correlation coefficient (r)</td><td align="left">0.9999</td><td align="left">0.9999</td><td align="left">0.9997</td><td align="left">0.9999</td></tr><tr><td align="left">Accuracy (Mean&#x02009;&#x000b1;&#x02009;SD)</td><td align="left">101.07&#x02009;&#x000b1;&#x02009;0.89</td><td align="left">100.70&#x02009;&#x000b1;&#x02009;0.78</td><td align="left">99.69&#x02009;&#x000b1;&#x02009;1.56</td><td align="left">100.12&#x02009;&#x000b1;&#x02009;0.70</td></tr><tr><td align="left">Precision (%RSD)</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#x000a0;Repeatability<sup>a</sup></td><td align="left">&#x02009;&#x000b1;&#x02009;0.88</td><td align="left">&#x02009;&#x000b1;&#x02009;0.78</td><td align="left">&#x02009;&#x000b1;&#x02009;1.57</td><td align="left">&#x02009;&#x000b1;&#x02009;0.70</td></tr><tr><td align="left">&#x000a0;Intermediate precision</td><td align="left">&#x02009;&#x000b1;&#x02009;1.22</td><td align="left">&#x02009;&#x000b1;&#x02009;0.73</td><td align="left">&#x02009;&#x000b1;&#x02009;1.48</td><td align="left">&#x02009;&#x000b1;&#x02009;1.03</td></tr><tr><td align="left">Specificity (Mean&#x02009;&#x000b1;&#x02009;SD)</td><td align="left">101.98&#x02009;&#x000b1;&#x02009;1.25</td><td align="left">100.89&#x02009;&#x000b1;&#x02009;0.88</td><td align="left">97.99&#x02009;&#x000b1;&#x02009;0.90</td><td align="left">99.99&#x02009;&#x000b1;&#x02009;1.10</td></tr><tr><td align="left">Specificity and selectivity</td><td align="left"/><td align="left"/><td align="left"/><td align="left">Resolution values (1.25 &#x00026; 2.22)</td></tr><tr><td align="left">Range (&#x000b5;g mL<sup>&#x02212;1</sup>)</td><td align="left">1.00&#x02013;300.00</td><td align="left">10.00&#x02013;500.00</td><td align="left">0.30&#x02013;50.00</td><td align="left">0.10&#x02013;50.00</td></tr><tr><td align="left">Robustness (%RSD)</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Resolution (R<sub>S</sub>)</td><td align="left">1.38</td><td align="left">1.18</td><td align="left">1.07</td><td align="left">0.94</td></tr><tr><td align="left">Symmetry factor (T)</td><td align="left">1.01</td><td align="left">1.01</td><td align="left">1.00</td><td align="left">1.94</td></tr><tr><td align="left">LOD<sup>c</sup> (&#x000b5;g mL<sup>&#x02212;1</sup>)</td><td align="left">0.31</td><td align="left">5.11</td><td align="left">0.08</td><td align="left">0.03</td></tr><tr><td align="left">LOQ<sup>c</sup> (&#x000b5;g mL<sup>&#x02212;1</sup>)</td><td align="left">0.94</td><td align="left">9.27</td><td align="left">0.25</td><td align="left">0.09</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>Intraday precision (the RSD of three different concentrations (1.00, 10.00, 50.00 &#x003bc;g mL<sup>&#x02212;1</sup> for GUF, 10.00, 100.00, 300.00 &#x003bc;g mL<sup>&#x02212;1</sup> for MET, 10.00, 200.00, 500.00 &#x003bc;g mL<sup>&#x02212;1</sup> for ASP and 1.00, 10.00, 50.00 &#x003bc;g mL<sup>&#x02212;1</sup> for SA) / 3 replicates each, within the same day)</p><p><sup>b</sup>Interday precision (the RSD of three different concentrations (1.00, 10.00, 50.00 &#x003bc;g mL<sup>&#x02212;1</sup> for GUF, 10.00, 100.00, 300.00 &#x003bc;g mL<sup>&#x02212;1</sup> for MET, 10.00, 200.00, 500.00 &#x003bc;g mL<sup>&#x02212;1</sup> for ASP and 1.00, 10.00, 50.00 &#x003bc;g mL<sup>&#x02212;1</sup> for SA)/3 replicates each, repeated on 2 successive days)</p><p><sup>c</sup>Limit of detection and quantitation are determined via calculations, LOD&#x02009;=&#x02009;(SD of the response/slope)&#x02009;&#x000d7;&#x02009;3.3; LOQ&#x02009;=&#x02009;(SD of the response/slope)&#x02009;&#x000d7;&#x02009;10</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec22"><title>Accuracy</title><p id="Par30">Accuracy was assessed by calculating the percentage recovery for three replicates of three different concentrations covering the linearity range for the studied drugs as presented in Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref><bold>.</bold></p></sec><sec id="Sec23"><title>Precision</title><p id="Par31">Precision was evaluated by the analysis of three concentration levels within the day and for three successive days for both repeatability and intermediate precision, respectively. The results were presented in Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>.</p></sec><sec id="Sec24"><title>LOD and LOQ</title><p id="Par32">Regarding the limits of quantification (LOQ) and limit of detection (LOD), they were calculated based on the standard deviations of intercepts. Table <xref rid="Tab2" ref-type="table">2</xref> shows results of limit of detection and quantitation that are determined via calculations, LOD&#x02009;=&#x02009;(SD of the response/slope)&#x02009;&#x000d7;&#x02009;3.3; LOQ&#x02009;=&#x02009;(SD of the response/slope)&#x02009;&#x000d7;&#x02009;10.</p></sec><sec id="Sec25"><title>Robustness</title><p id="Par33">In order to assess the robustness of the suggested HPLC method, we examined the impact of minute deliberate adjustments to the resolution (Rs) and symmetry factor (T) of the experimental condition. Among these variations were different methanol composition of 70.00&#x02009;&#x000b1;&#x02009;5.00% as the mobile phase, pH values change (3.00&#x02009;&#x000b1;&#x02009;0.20), wave length change (254.00&#x02009;&#x000b1;&#x02009;5 nm) and temperature change (20.00&#x02009;&#x000b1;&#x02009;5.00&#x000a0;&#x02103;). The values of each parameter were altered while the others remained unchanged. The fact that these small modifications to the experimental setup had no discernible effect on the reproducibility or repeatability of the procedure as illustrated in Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref> according to the obtained relative standard deviations (%RSD) which indicates how reliable the developed method is.</p></sec><sec id="Sec26"><title>Specificity</title><p id="Par34">Several laboratory prepared mixtures containing different concentrations of the studied drugs and their related impurities were evaluated in order to ascertain the method specificity. Satisfactory results were obtained indicating the high selectivity of the proposed method as presented in Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>.</p></sec></sec><sec id="Sec27"><title>Application to pharmaceutical formulation</title><p id="Par35">The recommended HPLC method was effectively implemented to ascertain MET and ASP in their pharmaceutical formulation Robaxisal extra strength&#x000ae; tablet. Table <xref rid="Tab3" ref-type="table">3</xref> displays the acquired results that demonstrate a strong correlation with the labeled values of the two medications in their tablet dosage form, showing the precision and selectivity of the presented method. No interference from excipients was revealed when the standard addition technique was applied to assess the validity of the method for the dosage form.<table-wrap id="Tab3"><label>Table&#x000a0;3</label><caption><p>Determination of MET and ASP in Robaxisal extra strength&#x000ae; tablet by the proposed HPLC method and application of standard addition technique</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Pharmaceutical Formulation</th><th align="left" rowspan="2">Drug</th><th align="left" rowspan="2">Proposed method % Recovery<break/>(mean&#x02009;&#x000b1;&#x02009;SD)</th><th align="left" colspan="4">Standard Addition</th></tr><tr><th align="left">Taken<break/>(&#x003bc;g mL<sup>&#x02212;1</sup>)</th><th align="left">Added<break/>(&#x003bc;g mL<sup>&#x02212;1</sup>)</th><th align="left">Standard found<break/>(&#x003bc;g mL<sup>&#x02212;1</sup>)</th><th align="left">% Recovery of added</th></tr></thead><tbody><tr><td align="left" rowspan="8"><p>Robaxisal extra strength&#x000ae; tablet labeled to contain 400.00 mg MET and</p><p>500.00 mg ASP/ tablet</p><p>(Batch No. PAA168448)</p></td><td align="left" rowspan="4">MET</td><td align="left" rowspan="4">100.42&#x02009;&#x000b1;&#x02009;1.66 <sup>a</sup></td><td align="left">100.00</td><td align="left">50.00</td><td char="." align="char">49.31</td><td char="." align="char">98.61</td></tr><tr><td align="left">100.00</td><td align="left">100.00</td><td char="." align="char">100.13</td><td char="." align="char">100.13</td></tr><tr><td align="left">100.00</td><td align="left">150.00</td><td char="." align="char">152.85</td><td char="." align="char">101.90</td></tr><tr><td align="left" colspan="2">Mean R%&#x02009;&#x000b1;&#x02009;SD</td><td align="left" colspan="2">100.21&#x02009;&#x000b1;&#x02009;1.65</td></tr><tr><td align="left" rowspan="4">ASP</td><td align="left" rowspan="4">99.53&#x02009;&#x000b1;&#x02009;1.21 <sup>b</sup></td><td align="left">125.00</td><td align="left">50.00</td><td char="." align="char">49.76</td><td char="." align="char">99.51</td></tr><tr><td align="left">125.00</td><td align="left">100.00</td><td char="." align="char">100.02</td><td char="." align="char">100.02</td></tr><tr><td align="left">125.00</td><td align="left">200.00</td><td char="." align="char">202.01</td><td char="." align="char">101.00</td></tr><tr><td align="left" colspan="2">Mean R%&#x02009;&#x000b1;&#x02009;SD</td><td align="left" colspan="2">100.18&#x02009;&#x000b1;&#x02009;0.76</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>Results of analysis 100.00 &#x003bc;g mL<sup>&#x02212;1</sup> of MET three times</p><p><sup>b</sup>Results of analysis 125.00 &#x003bc;g mL<sup>&#x02212;1</sup> of ASP three times</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec28"><title>Application to spiked human plasma</title><p id="Par36">The proposed method offered a rapid, selective and sensitive approach for monitoring MET and ASP levels in spiked human plasma that is suitable for pharmacokinetic or bioequivalence research studies. We applied direct injection method without time consuming extraction procedures [<xref ref-type="bibr" rid="CR37">37</xref>&#x02013;<xref ref-type="bibr" rid="CR41">41</xref>], showing promising results in Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>.<table-wrap id="Tab4"><label>Table&#x000a0;4</label><caption><p>Determination of MET and ASP in spiked plasma by the developed HPLC method</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="2">Drug</th><th align="left">MET</th><th align="left">ASP</th></tr><tr><th align="left">Recovery %&#x02009;&#x000b1;&#x02009;SD</th><th align="left">Recovery %&#x02009;&#x000b1;&#x02009;SD</th></tr></thead><tbody><tr><td align="left">Spiked Human Plasma</td><td align="left" colspan="2">101.07&#x02009;&#x000b1;&#x02009;0.89 <sup>a</sup></td><td align="left">100.70&#x02009;&#x000b1;&#x02009;0.78 <sup>b</sup></td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>Results of analysis 100.00 &#x003bc;g mL<sup>&#x02212;1</sup> MET three times</p><p><sup>b</sup>Results of analysis 100.00 &#x003bc;g mL<sup>&#x02212;1</sup> of ASP three times</p></table-wrap-foot></table-wrap></p><p id="Par37">In order to compare the data resulted from both the proposed HPLC method and the reported one [<xref ref-type="bibr" rid="CR29">29</xref>], the statistical F-test and Student t-test were applied. Table <xref rid="Tab5" ref-type="table">5</xref> illustrates that the measured F- and t-values were found to be below the critical values, indicating no significant difference with respect to accuracy.<table-wrap id="Tab5"><label>Table&#x000a0;5</label><caption><p>Statistical comparison of the results obtained by the proposed HPLC method and a reported HPLC method [<xref ref-type="bibr" rid="CR29">29</xref>] to determine MET, ASP, GUF and SA in pure powder form</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Drug</th><th align="left" colspan="2">MET</th><th align="left" colspan="2">ASP</th><th align="left" colspan="2">GUF</th><th align="left" colspan="2">SA</th></tr><tr><th align="left">Parameters</th><th align="left">Reported method*</th><th align="left">Proposed method</th><th align="left">Reported method*</th><th align="left">Proposed method</th><th align="left">Reported method*</th><th align="left">Proposed method</th><th align="left">Reported method*</th><th align="left">Proposed method</th></tr></thead><tbody><tr><td align="left">Mean</td><td align="left">100.12</td><td align="left">101.07</td><td align="left">100.98</td><td align="left">100.70</td><td align="left">100.11</td><td align="left">99.69</td><td align="left">101.02</td><td align="left">100.12</td></tr><tr><td align="left">SD</td><td align="left">1.77</td><td align="left">0.89</td><td align="left">1.52</td><td align="left">0.78</td><td align="left">1.62</td><td align="left">1.56</td><td align="left">0.87</td><td align="left">0.70</td></tr><tr><td align="left">RSD%</td><td align="left">1.77</td><td align="left">0.88</td><td align="left">1.51</td><td align="left">0.78</td><td align="left">1.62</td><td align="left">1.57</td><td align="left">0.86</td><td align="left">0.70</td></tr><tr><td align="left">n</td><td align="left">6</td><td align="left">6</td><td align="left">6</td><td align="left">6</td><td align="left">6</td><td align="left">6</td><td align="left">6</td><td align="left">6</td></tr><tr><td align="left">Variance</td><td align="left">3.13</td><td align="left">0.79</td><td align="left">2.31</td><td align="left">0.61</td><td align="left">2.62</td><td align="left">2.43</td><td align="left">0.76</td><td align="left">0.49</td></tr><tr><td align="left"><p>F-value</p><p>(p&#x02009;=&#x02009;0.05)</p></td><td align="left">&#x02013;</td><td align="left"><p>3.96</p><p>(4.28)</p></td><td align="left">&#x02013;</td><td align="left"><p>3.79</p><p>(4.28)</p></td><td align="left">&#x02013;</td><td align="left"><p>1.08</p><p>(4.28)</p></td><td align="left">&#x02013;</td><td align="left"><p>1.55</p><p>(4.28)</p></td></tr><tr><td align="left"><p>Student&#x02019;s</p><p>t-test</p></td><td align="left">&#x02013;</td><td align="left"><p>1.18</p><p>(2.44)</p></td><td align="left">&#x02013;</td><td align="left"><p>0.40</p><p>(2.44)</p></td><td align="left">&#x02013;</td><td align="left"><p>0.46</p><p>(2.44)</p></td><td align="left">&#x02013;</td><td align="left"><p>1.97</p><p>(2.44)</p></td></tr></tbody></table><table-wrap-foot><p>The figures between parenthesis are the corresponding theoretical values of F &#x00026; t at p&#x02009;=&#x02009;0.05</p><p><sup>*</sup>HPLC method C<sub>18</sub> column using isocratic elution system of diluted acetic acid (pH 3.2): acetonitrile at the ratio of 79: 21, v/v, at a flow rate of 1&#x000a0;mL&#x000a0;min<sup>&#x02212;1</sup>. Detection was achieved at 233 nm for MET, GUF and SA and at 273&#x000a0;nm for ASP</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec29"><title>Greenness assessment of the developed method</title><p id="Par38">Nowadays, researchers focus on establishing green analytical chemistry (GAC) rather than developing validated analytical method. The developed method was evaluated utilizing two green analytical assessment tools namely; Analytical Eco-Scale and AGREE approaches [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>]. The first applied approach is the Analytical Eco-Scale, it is a thorough tool for evaluating analytical procedures in a semi-quantitative manner. Table <xref rid="Tab6" ref-type="table">6</xref> illustrates the detailed total penalty points for our proposed HPLC method versus a reported HPLC one [<xref ref-type="bibr" rid="CR29">29</xref>]. In order to evaluate the analytical procedure, a value of penalty points is assigned to each step and subtracted from a base of 100. The second approach is AGREE which is considered one of the recent greenness tools of assessment. As presented in Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>, the circle becomes green when the score comes close to one. The suggested method received a score of 0.75, indicating greater greenness compared to reported HPLC and spectrophotometric methods [<xref ref-type="bibr" rid="CR29">29</xref>]. Finally, based on the obtained data, the proposed approach yielded a green analytical profile.<table-wrap id="Tab6"><label>Table&#x000a0;6</label><caption><p>Penalty points for using the proposed HPLC method and a reported HPLC method [<xref ref-type="bibr" rid="CR29">29</xref>]</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Reagents</th><th align="left">Proposed HPLC method<break/>Penalty points</th><th align="left">Reported HPLC method<break/>Penalty points</th></tr></thead><tbody><tr><td align="left">Methanol</td><td align="left">6</td><td align="left">0</td></tr><tr><td align="left">Water</td><td align="left">0</td><td align="left">0</td></tr><tr><td align="left">Triethylamine</td><td align="left">6</td><td align="left">0</td></tr><tr><td align="left">Acetonitrile</td><td align="left">0</td><td align="left">6</td></tr><tr><td align="left">Acetic acid</td><td align="left">0</td><td align="left">4</td></tr><tr><td align="left">O-phosphoric acid</td><td align="left">4</td><td align="left">0</td></tr><tr><td align="left"><italic>Instruments</italic>: HPLC</td><td align="left">1</td><td align="left">1</td></tr><tr><td align="left">Occupational hazard</td><td align="left">3</td><td align="left">3</td></tr><tr><td align="left">Waste</td><td align="left">8</td><td align="left">6</td></tr><tr><td align="left">Total penalty points</td><td align="left">28</td><td align="left">20</td></tr><tr><td align="left">Analytical Eco-scale total score</td><td align="left">72</td><td align="left">80</td></tr></tbody></table></table-wrap><fig id="Fig4"><label>Fig.&#x000a0;4</label><caption><p>AGREE green profile assessment of <bold>a</bold> the developed HPLC method to determine MET and ASP, <bold>b</bold> the reported HPLC method to determine MET and ASP</p></caption><graphic xlink:href="13065_2025_1500_Fig4_HTML" id="MO5"/></fig></p></sec><sec id="Sec30"><title>Whiteness assessment of the developed method</title><p id="Par39">The green aspects of the proposed HPLC method were assessed using the whiteness assessment approach [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. Red Green Blue (RGB) is considered as one of the most published multi-criteria assessments techniques and the results were presented in Table&#x000a0;<xref rid="Tab7" ref-type="table">7</xref> and Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>. Through the computational and obtained results for whiteness assessment, our developed HPLC method is considered greener and more eco-friendly than the reported HPLC and spectrophotometric methods [<xref ref-type="bibr" rid="CR27">27</xref>&#x02013;<xref ref-type="bibr" rid="CR29">29</xref>].<table-wrap id="Tab7"><label>Table&#x000a0;7</label><caption><p>RGB profiles of the developed HPLC method and other reported methods</p></caption><graphic position="anchor" xlink:href="13065_2025_1500_Tab7_HTML" id="MO6"/><table-wrap-foot><p>Whiteness % indicates the arithmetic mean of the three others % (red, green and blue)</p></table-wrap-foot></table-wrap><fig id="Fig5"><label>Fig.&#x000a0;5</label><caption><p>Comparison of the results obtained from RGB analysis for the developed HPLC method with the reported HPLC and spectrophotometric methods</p></caption><graphic xlink:href="13065_2025_1500_Fig5_HTML" id="MO7"/></fig></p><p id="Par40">Table <xref rid="Tab8" ref-type="table">8</xref> provided a summary of some of the key outcomes from the suggested approach and the former mentioned HPLC method [<xref ref-type="bibr" rid="CR29">29</xref>]. Eventually, our presented method is more sensitive, economic and time-saving with a shorter run time. Besides, it can detect a wider range and lower concentrations of the intended drugs with wider application in spiked human plasma compared to the reported HPLC method. The developed work also has low impact on the ecosystem. Although the results obtained from the Analytical Eco-Scale were better than our suggested method, AGREE and Whiteness assessments showed superior outcomes for the proposed method. Additionally, molecular docking was novelly employed to ascertain the elution arrangement for the four studied compounds. Consequently, the worked HPLC method describes an eco-friendly, sensitive and cost-effective stability indicating assay to simultaneously determine MET and ASP as well as their related substances GUF and SA, respectively.<table-wrap id="Tab8"><label>Table&#x000a0;8</label><caption><p>Comparison of the results obtained by the proposed HPLC and the reported one [<xref ref-type="bibr" rid="CR29">29</xref>]</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Parameters</th><th align="left" colspan="4">Proposed HPLC method</th><th align="left" colspan="4">Reported HPLC method</th></tr><tr><th align="left">MET</th><th align="left">ASP</th><th align="left">GUF</th><th align="left">SA</th><th align="left">MET</th><th align="left">ASP</th><th align="left">GUF</th><th align="left">SA</th></tr></thead><tbody><tr><td align="left">Range (&#x000b5;g&#x000a0;mL<sup>&#x02212;1</sup>)</td><td align="left">1.00&#x02013;300.00</td><td align="left">10.00&#x02013;500.00</td><td align="left">0.30&#x02013;50.00</td><td align="left">0.10&#x02013;50.00</td><td align="left">2.00&#x02013;150.00</td><td align="left">25.00&#x02013;450.00</td><td align="left">0.40&#x02013;3.00</td><td align="left">0.20&#x02013;27.00</td></tr><tr><td align="left">R<sub>t</sub> (min)</td><td align="left">4.20</td><td align="left">4.50</td><td align="left">3.70</td><td align="left">6.50</td><td align="left">5.07</td><td align="left">5.81</td><td align="left">4.15</td><td align="left">7.84</td></tr><tr><td align="left">Total run time (min)</td><td align="left" colspan="4">8</td><td align="left" colspan="4">9</td></tr><tr><td align="left"><p>Analytical Eco-scale</p><p>(penalty points)</p></td><td align="left" colspan="4">72</td><td align="left" colspan="4">80</td></tr><tr><td align="left">Whiteness evaluation (%)</td><td align="left" colspan="4">99.70</td><td align="left" colspan="4">95.00</td></tr><tr><td align="left">AGREE</td><td align="left" colspan="4">0.75</td><td align="left" colspan="4">0.72</td></tr></tbody></table></table-wrap></p></sec></sec><sec id="Sec31"><title>Conclusion</title><p id="Par41">Through several analytical trials, the proposed research offered high sensitivity, precision and accuracy, which makes it suitable for the routine analysis besides the simultaneous separation and quantification of MET, ASP and their related impurities and degradation products GUF and SA, respectively in their pure form and in their combined pharmaceutical formulation. Furthermore, the developed approach has been successfully applied to determine the studied drugs in spiked human plasma. Utilizing HPLC technique to separate MET, ASP and their related impurities GUF and SA provided several advantages over the published method in reducing analysis time and thus reduce solvents consumption through separation of the studied drugs all in a single run. Additionally, by utilizing molecular dynamic simulation, the separation power was linked to the computational outcomes. Moreover, in addition to offering these benefits, the suggested HPLC approach is environmentally friendly and green. Analytical Eco-Scale and AGREE approaches beside whiteness assessment were applied to measure the environmental impact for the present work. Consequently, the discussed HPLC method offers more rapid analysis and more economic additionally environmentally sustainable.</p></sec><sec id="Sec32" sec-type="supplementary-material"><title>Supplementary Information</title><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="13065_2025_1500_MOESM1_ESM.docx"><caption><p>Supplementary Material 1.</p></caption></media></supplementary-material></p></sec></body><back><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>Not applicable.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>Authors contribution statement Maha M Ibrahim: Writing&#x02014;original draft, Validation, Software, Methodology, analysis, Data curation. Asmaa M. AboulMagd: Writing and editing, Molecular Docking, Data curation. Yasmine F Bassuoni: writing&#x02014;review and editing, analysis, Validation, Methodology.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>Open access funding provided by The Science, Technology &#x00026; Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB).</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>All data generated or analyzed during this study are included in this article.</p></notes><notes><title>Declarations</title><notes id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par42">Ethical Committee Approval was attained by the Committee of Ethics for Scientific Research on Living Organisms, Faculty of Pharmacy, Nahda University in Beni-Suef (NUB). The approval number was (NUB-025-041). The studies have not involved any human volunteers or animals and the plasma samples were obtained from a blood bank in Egypt.</p></notes><notes id="FPar2" notes-type="COI-statement"><title>Competing interests</title><p id="Par43">The authors declare no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Rahman</surname><given-names>N</given-names></name><name><surname>Azmi</surname><given-names>SNH</given-names></name><name><surname>Wu</surname><given-names>H-F</given-names></name></person-group><article-title>The importance of impurity analysis in pharmaceutical products: an integrated approach</article-title><source>Accredit Qual Assur</source><year>2006</year><volume>11</volume><fpage>69</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1007/s00769-006-0095-y</pub-id></element-citation><mixed-citation id="mc-CR1" publication-type="journal">Rahman N, Azmi SNH, Wu H-F. The importance of impurity analysis in pharmaceutical products: an integrated approach. Accredit Qual Assur. 2006;11:69&#x02013;74.</mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>RN</given-names></name><name><surname>Nagaraju</surname><given-names>V</given-names></name></person-group><article-title>An overview of the recent trends in development of HPLC methods for determination of impurities in drugs</article-title><source>J Pharm Biomed Anal</source><year>2003</year><volume>33</volume><fpage>335</fpage><lpage>377</lpage><pub-id pub-id-type="doi">10.1016/S0731-7085(03)00293-0</pub-id><pub-id pub-id-type="pmid">14550856</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Rao RN, Nagaraju V. An overview of the recent trends in development of HPLC methods for determination of impurities in drugs. J Pharm Biomed Anal. 2003;33:335&#x02013;77.<pub-id pub-id-type="pmid">14550856</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>G&#x000f6;r&#x000f6;g</surname><given-names>S</given-names></name></person-group><article-title>Critical review of reports on impurity and degradation product profiling in the last decade</article-title><source>TrAC Trends Anal Chem</source><year>2018</year><volume>101</volume><fpage>2</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1016/j.trac.2017.09.012</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">G&#x000f6;r&#x000f6;g S. Critical review of reports on impurity and degradation product profiling in the last decade. TrAC Trends Anal Chem. 2018;101:2&#x02013;16.</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Pooja</surname><given-names>SM</given-names></name><name><surname>Patil</surname><given-names>PH</given-names></name><name><surname>Sananp</surname><given-names>G</given-names></name><name><surname>Kathar</surname><given-names>NP</given-names></name><name><surname>Aishwarya</surname><given-names>PP</given-names></name></person-group><article-title>A review on high performance liquid chromatography (HPLC)</article-title><source>Int J Res Trends Innov</source><year>2022</year><volume>7</volume><fpage>2456</fpage><lpage>3315</lpage></element-citation><mixed-citation id="mc-CR4" publication-type="journal">Pooja SM, Patil PH, Sananp G, Kathar NP, Aishwarya PP. A review on high performance liquid chromatography (HPLC). Int J Res Trends Innov. 2022;7:2456&#x02013;3315.</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Armenta</surname><given-names>S</given-names></name><name><surname>Garrigues</surname><given-names>S</given-names></name><name><surname>de la Guardia</surname><given-names>M</given-names></name></person-group><article-title>Green analytical chemistry</article-title><source>TrAC Trends Anal Chem</source><year>2008</year><volume>27</volume><fpage>497</fpage><lpage>511</lpage><pub-id pub-id-type="doi">10.1016/j.trac.2008.05.003</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Armenta S, Garrigues S, de la Guardia M. Green analytical chemistry. TrAC Trends Anal Chem. 2008;27:497&#x02013;511.</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Marcinkowska</surname><given-names>R</given-names></name><name><surname>Namie&#x0015b;nik</surname><given-names>J</given-names></name><name><surname>Tobiszewski</surname><given-names>M</given-names></name></person-group><article-title>Green and equitable analytical chemistry</article-title><source>Curr Opin Green Sustain Chem</source><year>2019</year><volume>19</volume><fpage>19</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1016/j.cogsc.2019.04.003</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Marcinkowska R, Namie&#x0015b;nik J, Tobiszewski M. Green and equitable analytical chemistry. Curr Opin Green Sustain Chem. 2019;19:19&#x02013;23.</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Nowak</surname><given-names>PM</given-names></name><name><surname>Wietecha-Pos&#x00142;uszny</surname><given-names>R</given-names></name><name><surname>Pawliszyn</surname><given-names>J</given-names></name></person-group><article-title>White analytical chemistry: an approach to reconcile the principles of green analytical chemistry and functionality</article-title><source>TrAC Trends Anal Chem</source><year>2021</year><volume>138</volume><fpage>116223</fpage><pub-id pub-id-type="doi">10.1016/j.trac.2021.116223</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">Nowak PM, Wietecha-Pos&#x00142;uszny R, Pawliszyn J. White analytical chemistry: an approach to reconcile the principles of green analytical chemistry and functionality. TrAC Trends Anal Chem. 2021;138:116223.</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Nowak</surname><given-names>PM</given-names></name><name><surname>Ko&#x0015b;cielniak</surname><given-names>P</given-names></name></person-group><article-title>What color is your method? Adaptation of the RGB additive color model to analytical method evaluation</article-title><source>Anal Chem</source><year>2019</year><pub-id pub-id-type="doi">10.1021/acs.analchem.9b01872</pub-id><pub-id pub-id-type="pmid">31305064</pub-id>
</element-citation><mixed-citation id="mc-CR8" publication-type="journal">Nowak PM, Ko&#x0015b;cielniak P. What color is your method? Adaptation of the RGB additive color model to analytical method evaluation. Anal Chem. 2019. 10.1021/acs.analchem.9b01872.<pub-id pub-id-type="pmid">31305064</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Jameson</surname><given-names>CJ</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Murad</surname><given-names>S</given-names></name></person-group><article-title>Molecular dynamics simulations of enantiomeric separations as an interfacial process in HPLC</article-title><source>AIChE J</source><year>2020</year><volume>67</volume><fpage>e17143</fpage><pub-id pub-id-type="doi">10.1002/aic.17143</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Jameson CJ, Wang X, Murad S. Molecular dynamics simulations of enantiomeric separations as an interfacial process in HPLC. AIChE J. 2020;67: e17143.</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Kelani</surname><given-names>KM</given-names></name><name><surname>Fayez</surname><given-names>YM</given-names></name><name><surname>Abdel-Raoof</surname><given-names>AM</given-names></name><name><surname>Fekry</surname><given-names>RA</given-names></name><name><surname>Hassan</surname><given-names>SA</given-names></name></person-group><article-title>Development of an eco-friendly HPLC method for the stability indicating assay of binary mixture of ibuprofen and phenylephrine</article-title><source>BMC Chem</source><year>2023</year><volume>17</volume><fpage>141</fpage><pub-id pub-id-type="doi">10.1186/s13065-023-01056-4</pub-id><pub-id pub-id-type="pmid">37876006</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Kelani KM, Fayez YM, Abdel-Raoof AM, Fekry RA, Hassan SA. Development of an eco-friendly HPLC method for the stability indicating assay of binary mixture of ibuprofen and phenylephrine. BMC Chem. 2023;17:141.<pub-id pub-id-type="pmid">37876006</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Lindsey</surname><given-names>RK</given-names></name><name><surname>Rafferty</surname><given-names>JL</given-names></name><name><surname>Eggimann</surname><given-names>BL</given-names></name><name><surname>Siepmann</surname><given-names>JI</given-names></name><name><surname>Schure</surname><given-names>MR</given-names></name></person-group><article-title>Molecular simulation studies of reversed-phase liquid chromatography</article-title><source>J Chromatogr A</source><year>2013</year><volume>26</volume><fpage>60</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1016/j.chroma.2013.02.040</pub-id></element-citation><mixed-citation id="mc-CR11" publication-type="journal">Lindsey RK, Rafferty JL, Eggimann BL, Siepmann JI, Schure MR. Molecular simulation studies of reversed-phase liquid chromatography. J Chromatogr A. 2013;26:60&#x02013;82.</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Nemala</surname><given-names>AR</given-names></name><name><surname>Sridevi Chigurupati</surname><given-names>KKS</given-names></name><name><surname>Bhatia</surname><given-names>S</given-names></name><name><surname>Pingali</surname><given-names>S</given-names></name><name><surname>Sadula</surname><given-names>A</given-names></name></person-group><article-title>Identification, synthesis, and characterization of &#x003b2;-isomer as process related impurity in production of methocarbamol from guaifenesin</article-title><source>J Appl Pharm Sci</source><year>2020</year><volume>10</volume><fpage>015</fpage><lpage>20</lpage></element-citation><mixed-citation id="mc-CR12" publication-type="journal">Nemala AR, Sridevi Chigurupati KKS, Bhatia S, Pingali S, Sadula A. Identification, synthesis, and characterization of &#x003b2;-isomer as process related impurity in production of methocarbamol from guaifenesin. J Appl Pharm Sci. 2020;10:015&#x02013;20.</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Higuchi</surname><given-names>S</given-names></name><name><surname>Tanaka</surname><given-names>N</given-names></name><name><surname>Shioiri</surname><given-names>Y</given-names></name><name><surname>Otomo</surname><given-names>S</given-names></name><name><surname>Aihara</surname><given-names>H</given-names></name></person-group><article-title>Two modes of analgesic action of aspirin, and the site of analgesic action of salicylic acid</article-title><source>Int J Tissue React</source><year>1986</year><volume>8</volume><fpage>327</fpage><lpage>331</lpage><pub-id pub-id-type="pmid">3091522</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Higuchi S, Tanaka N, Shioiri Y, Otomo S, Aihara H. Two modes of analgesic action of aspirin, and the site of analgesic action of salicylic acid. Int J Tissue React. 1986;8:327&#x02013;31.<pub-id pub-id-type="pmid">3091522</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><mixed-citation publication-type="other">United States Pharmacopoeia and National Formulary. (USP 43-NF 38) Rockv United States Pharmacopoeia Conv. 2019.</mixed-citation></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Kalia</surname><given-names>S</given-names></name><name><surname>Nath</surname><given-names>P</given-names></name><name><surname>Pathak</surname><given-names>M</given-names></name><name><surname>Anand</surname><given-names>AC</given-names></name></person-group><article-title>Treatment of muscle cramps in patients with cirrhosis of liver: a systematic review</article-title><source>J Clin Exp Hepatol</source><year>2022</year><volume>12</volume><fpage>980</fpage><lpage>992</lpage><pub-id pub-id-type="doi">10.1016/j.jceh.2021.10.147</pub-id><pub-id pub-id-type="pmid">35677500</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Kalia S, Nath P, Pathak M, Anand AC. Treatment of muscle cramps in patients with cirrhosis of liver: a systematic review. J Clin Exp Hepatol. 2022;12:980&#x02013;92.<pub-id pub-id-type="pmid">35677500</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Walash</surname><given-names>M</given-names></name><name><surname>Belal</surname><given-names>F</given-names></name><name><surname>Eid</surname><given-names>M</given-names></name><name><surname>EL Abass</surname><given-names>SA</given-names></name></person-group><article-title>Spectrofluorometric determination of methocarbamol in pharmaceutical preparations and human plasma</article-title><source>J Fluoresc</source><year>2011</year><volume>21</volume><fpage>555</fpage><lpage>561</lpage><pub-id pub-id-type="doi">10.1007/s10895-010-0742-x</pub-id><pub-id pub-id-type="pmid">20936330</pub-id>
</element-citation><mixed-citation id="mc-CR16" publication-type="journal">Walash M, Belal F, Eid M, EL Abass SA. Spectrofluorometric determination of methocarbamol in pharmaceutical preparations and human plasma. J Fluoresc. 2011;21:555&#x02013;61.<pub-id pub-id-type="pmid">20936330</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Ghoneim</surname><given-names>EM</given-names></name><name><surname>El-Desoky</surname><given-names>HS</given-names></name></person-group><article-title>Electrochemical determination of methocarbamol on a montmorillonite-Ca modified carbon paste electrode in formulation and human blood</article-title><source>Bioelectrochemistry</source><year>2010</year><volume>79</volume><fpage>241</fpage><lpage>247</lpage><pub-id pub-id-type="doi">10.1016/j.bioelechem.2010.06.005</pub-id><pub-id pub-id-type="pmid">20619752</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">Ghoneim EM, El-Desoky HS. Electrochemical determination of methocarbamol on a montmorillonite-Ca modified carbon paste electrode in formulation and human blood. Bioelectrochemistry. 2010;79:241&#x02013;7.<pub-id pub-id-type="pmid">20619752</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Vijayasree</surname><given-names>P</given-names></name><name><surname>Devika</surname><given-names>GS</given-names></name><name><surname>Sravani</surname><given-names>M</given-names></name><name><surname>Krishna</surname><given-names>GS</given-names></name><name><surname>Vali</surname><given-names>KD</given-names></name></person-group><article-title>Simple UV spectrophotometric estimation of methocarbamol by co-solubilization technique</article-title><source>Res J Pharm Technol</source><year>2014</year><volume>7</volume><fpage>2</fpage></element-citation><mixed-citation id="mc-CR18" publication-type="journal">Vijayasree P, Devika GS, Sravani M, Krishna GS, Vali KD. Simple UV spectrophotometric estimation of methocarbamol by co-solubilization technique. Res J Pharm Technol. 2014;7:2.</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Prabha</surname><given-names>T</given-names></name><name><surname>Nivethitha</surname><given-names>B</given-names></name><name><surname>Jagadeeshwaran</surname><given-names>M</given-names></name><name><surname>Sivakumar</surname><given-names>T</given-names></name></person-group><article-title>Method development, validation and degradation studies of methocarbamol from methocarbamol injection</article-title><source>Int J Pharm Sci Rev Res.</source><year>2018</year><volume>50</volume><fpage>169</fpage><lpage>174</lpage></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Prabha T, Nivethitha B, Jagadeeshwaran M, Sivakumar T. Method development, validation and degradation studies of methocarbamol from methocarbamol injection. Int J Pharm Sci Rev Res. 2018;50:169&#x02013;74.</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Rosasco</surname><given-names>MA</given-names></name><name><surname>Ceresole</surname><given-names>R</given-names></name><name><surname>Forastieri</surname><given-names>CC</given-names></name><name><surname>Segall</surname><given-names>AI</given-names></name></person-group><article-title>A stability-indicating high-performance liquid chromatographic method for the determination of methocarbamol in veterinary preparations</article-title><source>J AOAC Int</source><year>2009</year><volume>92</volume><fpage>1602</fpage><lpage>1605</lpage><pub-id pub-id-type="doi">10.1093/jaoac/92.5.1602</pub-id><pub-id pub-id-type="pmid">19916399</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Rosasco MA, Ceresole R, Forastieri CC, Segall AI. A stability-indicating high-performance liquid chromatographic method for the determination of methocarbamol in veterinary preparations. J AOAC Int. 2009;92:1602&#x02013;5.<pub-id pub-id-type="pmid">19916399</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>Zha</surname><given-names>W</given-names></name><name><surname>Zhu</surname><given-names>Z</given-names></name></person-group><article-title>Determination of methocarbamol concentration in human plasma by high performance liquid chromatography-tandem mass spectrometry</article-title><source>J Chromatogr B Analyt Technol Biomed Life Sci</source><year>2010</year><volume>878</volume><fpage>831</fpage><lpage>835</lpage><pub-id pub-id-type="doi">10.1016/j.jchromb.2010.01.025</pub-id><pub-id pub-id-type="pmid">20171150</pub-id>
</element-citation><mixed-citation id="mc-CR21" publication-type="journal">Zha W, Zhu Z. Determination of methocarbamol concentration in human plasma by high performance liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2010;878:831&#x02013;5.<pub-id pub-id-type="pmid">20171150</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Ali</surname><given-names>NW</given-names></name><name><surname>Hegazy</surname><given-names>MA</given-names></name><name><surname>Abdelkawy</surname><given-names>M</given-names></name><name><surname>Abdelaleem</surname><given-names>EA</given-names></name></person-group><article-title>Simultaneous determination of methocarbamol and its related substance (guaifenesin) in two ternary mixtures with ibuprofen and diclofenac potassium by RP-HPLC method</article-title><source>J Liq Chromatogr Relat Technol</source><year>2012</year><volume>35</volume><fpage>2229</fpage><lpage>2242</lpage><pub-id pub-id-type="doi">10.1080/10826076.2011.629393</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Ali NW, Hegazy MA, Abdelkawy M, Abdelaleem EA. Simultaneous determination of methocarbamol and its related substance (guaifenesin) in two ternary mixtures with ibuprofen and diclofenac potassium by RP-HPLC method. J Liq Chromatogr Relat Technol. 2012;35:2229&#x02013;42.</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Ali</surname><given-names>N</given-names></name><name><surname>Hegazy</surname><given-names>M</given-names></name><name><surname>Abdelkawy</surname><given-names>M</given-names></name><name><surname>Abdelaleem</surname><given-names>E</given-names></name></person-group><article-title>Simultaneous determination of methocarbamol and its related substance (Guaifenesin) in two ternary mixtures with ibuprofen and diclofenac potassium by HPTLC spectrodensitometric method</article-title><source>JPC J Planar Chromatogr Mod TLC</source><year>2012</year><volume>25</volume><fpage>150</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.1556/JPC.25.2012.2.11</pub-id></element-citation><mixed-citation id="mc-CR23" publication-type="journal">Ali N, Hegazy M, Abdelkawy M, Abdelaleem E. Simultaneous determination of methocarbamol and its related substance (Guaifenesin) in two ternary mixtures with ibuprofen and diclofenac potassium by HPTLC spectrodensitometric method. JPC J Planar Chromatogr Mod TLC. 2012;25:150&#x02013;5.</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><mixed-citation publication-type="other">Odwbg LY. Clarke&#x02019;s analysis of drugs and poisons. 3rd ed. London. Pharmaceutical Press; 2003.</mixed-citation></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="book"><person-group person-group-type="author"><name><surname>Sweetman</surname><given-names>SC</given-names></name></person-group><source>Martindale: the complete drug reference</source><year>2011</year><edition>37</edition><publisher-loc>London</publisher-loc><publisher-name>Pharmaceutical Press</publisher-name></element-citation><mixed-citation id="mc-CR25" publication-type="book">Sweetman SC. Martindale: the complete drug reference. 37th ed. London: Pharmaceutical Press; 2011.</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Mohamed</surname><given-names>SAEA</given-names></name><name><surname>Belal</surname><given-names>FF</given-names></name></person-group><article-title>A micellar HPLC method for simultaneous determination of methocarbamol in three different tablets using single run; application to human plasma and evaluation of the method greenness</article-title><source>Microchem J</source><year>2019</year><volume>148</volume><fpage>262</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.1016/j.microc.2019.04.079</pub-id></element-citation><mixed-citation id="mc-CR26" publication-type="journal">Mohamed SAEA, Belal FF. A micellar HPLC method for simultaneous determination of methocarbamol in three different tablets using single run; application to human plasma and evaluation of the method greenness. Microchem J. 2019;148:262&#x02013;9.</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>El-Din</surname><given-names>MS</given-names></name><name><surname>Eid</surname><given-names>M</given-names></name><name><surname>Zeid</surname><given-names>AM</given-names></name></person-group><article-title>Simultaneous determination of methocarbamol and aspirin by RP-HPLC using fluorescence detection with time programming: its application to pharmaceutical dosage form</article-title><source>Luminescence</source><year>2012</year><volume>28</volume><fpage>332</fpage><pub-id pub-id-type="doi">10.1002/bio.2386</pub-id><pub-id pub-id-type="pmid">22715138</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">El-Din MS, Eid M, Zeid AM. Simultaneous determination of methocarbamol and aspirin by RP-HPLC using fluorescence detection with time programming: its application to pharmaceutical dosage form. Luminescence. 2012;28:332.<pub-id pub-id-type="pmid">22715138</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>El-Din</surname><given-names>MS</given-names></name><name><surname>Eid</surname><given-names>M</given-names></name><name><surname>Zeid</surname><given-names>AM</given-names></name></person-group><article-title>Simultaneous determination of methocarbamol and aspirin binary mixture in their combined tablets by derivative and ratio derivative spectrophotometry</article-title><source>Anal Methods</source><year>2015</year><pub-id pub-id-type="doi">10.1039/C3AY42163E</pub-id></element-citation><mixed-citation id="mc-CR28" publication-type="journal">El-Din MS, Eid M, Zeid AM. Simultaneous determination of methocarbamol and aspirin binary mixture in their combined tablets by derivative and ratio derivative spectrophotometry. Anal Methods. 2015. 10.1039/C3AY42163E.</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>El-Yazbi</surname><given-names>FA</given-names></name><name><surname>Amin</surname><given-names>OA</given-names></name><name><surname>El-Kimary</surname><given-names>EI</given-names></name><name><surname>Khamis</surname><given-names>EF</given-names></name><name><surname>Younis</surname><given-names>SE</given-names></name></person-group><article-title>Simultaneous determination of methocarbamol and aspirin in presence of their pharmacopeial-related substances in combined tablets using novel HPLC-DAD method</article-title><source>Drug Dev Ind Pharm</source><year>2019</year><volume>45</volume><fpage>265</fpage><lpage>272</lpage><pub-id pub-id-type="doi">10.1080/03639045.2018.1535603</pub-id><pub-id pub-id-type="pmid">30307339</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">El-Yazbi FA, Amin OA, El-Kimary EI, Khamis EF, Younis SE. Simultaneous determination of methocarbamol and aspirin in presence of their pharmacopeial-related substances in combined tablets using novel HPLC-DAD method. Drug Dev Ind Pharm. 2019;45:265&#x02013;72.<pub-id pub-id-type="pmid">30307339</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Ga&#x00142;uszka</surname><given-names>A</given-names></name><name><surname>Migaszewski</surname><given-names>ZM</given-names></name><name><surname>Konieczka</surname><given-names>P</given-names></name><name><surname>Namie&#x0015b;nik</surname><given-names>J</given-names></name></person-group><article-title>Analytical Eco-Scale for assessing the greenness of analytical procedures</article-title><source>TrAC Trends Anal Chem</source><year>2012</year><volume>37</volume><fpage>61</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1016/j.trac.2012.03.013</pub-id></element-citation><mixed-citation id="mc-CR30" publication-type="journal">Ga&#x00142;uszka A, Migaszewski ZM, Konieczka P, Namie&#x0015b;nik J. Analytical Eco-Scale for assessing the greenness of analytical procedures. TrAC Trends Anal Chem. 2012;37:61&#x02013;72.</mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Moaaz</surname><given-names>EM</given-names></name><name><surname>Abdel-Moety</surname><given-names>EM</given-names></name><name><surname>Rezk</surname><given-names>MR</given-names></name><name><surname>Fayed</surname><given-names>AS</given-names></name></person-group><article-title>Eco-friendly chromatographic methods for determination of Acemetacin and indomethacin: Greenness Profile Assessment</article-title><source>J AOAC Int</source><year>2021</year><volume>104</volume><fpage>1485</fpage><lpage>1491</lpage><pub-id pub-id-type="doi">10.1093/jaoacint/qsab085</pub-id><pub-id pub-id-type="pmid">34180980</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Moaaz EM, Abdel-Moety EM, Rezk MR, Fayed AS. Eco-friendly chromatographic methods for determination of Acemetacin and indomethacin: Greenness Profile Assessment. J AOAC Int. 2021;104:1485&#x02013;91.<pub-id pub-id-type="pmid">34180980</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>Pena-Pereira</surname><given-names>F</given-names></name><name><surname>Wojnowski</surname><given-names>W</given-names></name><name><surname>Tobiszewski</surname><given-names>M</given-names></name></person-group><article-title>AGREE&#x02014;analytical GREEnness metric approach and software</article-title><source>Anal Chem</source><year>2020</year><volume>92</volume><fpage>10076</fpage><pub-id pub-id-type="doi">10.1021/acs.analchem.0c01887</pub-id><pub-id pub-id-type="pmid">32538619</pub-id>
</element-citation><mixed-citation id="mc-CR32" publication-type="journal">Pena-Pereira F, Wojnowski W, Tobiszewski M. AGREE&#x02014;analytical GREEnness metric approach and software. Anal Chem. 2020;92:10076.<pub-id pub-id-type="pmid">32538619</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><mixed-citation publication-type="other">ICH. International Conference on Harmonization (ICH) of Technical Require&#x000ac;ments for the Registration of Pharmaceuticals for Human Use, Validation of Analytical Procedures: Methodology. ICH-Q2 (R1). 2017. pp. 6&#x02013;13.</mixed-citation></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="book"><person-group person-group-type="author"><name><surname>Miguel de la Guardia</surname><given-names>SG</given-names></name></person-group><source>Handbook of green analytical chemistry</source><year>2012</year><publisher-loc>Hoboken</publisher-loc><publisher-name>John Wiley &#x00026; Sons Ltd</publisher-name></element-citation><mixed-citation id="mc-CR34" publication-type="book">Miguel de la Guardia SG. Handbook of green analytical chemistry. Hoboken: John Wiley &#x00026; Sons Ltd; 2012.</mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Jeelani</surname><given-names>S</given-names></name><name><surname>Kouznetsova</surname><given-names>N</given-names></name></person-group><article-title>A new stability-indicating HPLC-UV method for determination of amlodipine besylate and its impurities in drug substance</article-title><source>Heliyon</source><year>2023</year><volume>9</volume><fpage>e19993</fpage><pub-id pub-id-type="doi">10.1016/j.heliyon.2023.e19993</pub-id><pub-id pub-id-type="pmid">37809728</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">Jeelani S, Kouznetsova N. A new stability-indicating HPLC-UV method for determination of amlodipine besylate and its impurities in drug substance. Heliyon. 2023;9: e19993.<pub-id pub-id-type="pmid">37809728</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>JH</given-names></name><name><surname>Ryu</surname><given-names>YK</given-names></name><name><surname>Lim</surname><given-names>HJ</given-names></name><name><surname>Lee</surname><given-names>HS</given-names></name><name><surname>Park</surname><given-names>JK</given-names></name><name><surname>Lee</surname><given-names>YK</given-names></name><name><surname>Jang</surname><given-names>MD</given-names></name><name><surname>Suh</surname><given-names>JK</given-names></name><name><surname>Carr</surname><given-names>PW</given-names></name></person-group><article-title>Effect of triethylamine in the mobile phase on the retention properties of conventional polymeric and horizontally polymerized octadecylsilica in RPLC</article-title><source>Chromatographia</source><year>1999</year><volume>49</volume><fpage>635</fpage><lpage>642</lpage><pub-id pub-id-type="doi">10.1007/BF02466905</pub-id></element-citation><mixed-citation id="mc-CR36" publication-type="journal">Park JH, Ryu YK, Lim HJ, Lee HS, Park JK, Lee YK, Jang MD, Suh JK, Carr PW. Effect of triethylamine in the mobile phase on the retention properties of conventional polymeric and horizontally polymerized octadecylsilica in RPLC. Chromatographia. 1999;49:635&#x02013;42.</mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>Naguib</surname><given-names>IA</given-names></name><name><surname>Abdelaleem</surname><given-names>EA</given-names></name><name><surname>Emam</surname><given-names>AA</given-names></name><name><surname>Ali</surname><given-names>NW</given-names></name><name><surname>Abdallah</surname><given-names>FF</given-names></name></person-group><article-title>Development and validation of HPTLC and green HPLC methods for determination of furosemide, spironolactone and canrenone, in pure forms, tablets and spiked human plasma</article-title><source>Biomed Chromatogr</source><year>2019</year><volume>32</volume><fpage>1</fpage><lpage>9</lpage></element-citation><mixed-citation id="mc-CR37" publication-type="journal">Naguib IA, Abdelaleem EA, Emam AA, Ali NW, Abdallah FF. Development and validation of HPTLC and green HPLC methods for determination of furosemide, spironolactone and canrenone, in pure forms, tablets and spiked human plasma. Biomed Chromatogr. 2019;32:1&#x02013;9.</mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name><surname>Wadie</surname><given-names>M</given-names></name><name><surname>Abdel-Moety</surname><given-names>EM</given-names></name><name><surname>Rezk</surname><given-names>MR</given-names></name><name><surname>Marzouk</surname><given-names>HM</given-names></name></person-group><article-title>A novel eco-friendly HPLC method with dual detection modes for versatile quantification of dutasteride and silodosin in pharmaceutical formulation, dissolution testing and spiked human plasma</article-title><source>Microchem J</source><year>2024</year><volume>197</volume><fpage>109753</fpage><pub-id pub-id-type="doi">10.1016/j.microc.2023.109753</pub-id></element-citation><mixed-citation id="mc-CR38" publication-type="journal">Wadie M, Abdel-Moety EM, Rezk MR, Marzouk HM. A novel eco-friendly HPLC method with dual detection modes for versatile quantification of dutasteride and silodosin in pharmaceutical formulation, dissolution testing and spiked human plasma. Microchem J. 2024;197:109753.</mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name><surname>Essam</surname><given-names>HM</given-names></name><name><surname>Bassuoni</surname><given-names>YF</given-names></name><name><surname>Elzanfaly</surname><given-names>ES</given-names></name><name><surname>Zaazaa</surname><given-names>HE</given-names></name><name><surname>Kelani</surname><given-names>KM</given-names></name></person-group><article-title>Potentiometric sensing platform for selective determination and monitoring of codeine phosphate in presence of ibuprofen in pharmaceutical and biological matrices</article-title><source>Microchem J</source><year>2020</year><volume>159</volume><fpage>105286</fpage><pub-id pub-id-type="doi">10.1016/j.microc.2020.105286</pub-id></element-citation><mixed-citation id="mc-CR39" publication-type="journal">Essam HM, Bassuoni YF, Elzanfaly ES, Zaazaa HE, Kelani KM. Potentiometric sensing platform for selective determination and monitoring of codeine phosphate in presence of ibuprofen in pharmaceutical and biological matrices. Microchem J. 2020;159:105286.</mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name><surname>Hesham</surname><given-names>N</given-names></name><name><surname>Hegazy</surname><given-names>MA</given-names></name><name><surname>Wagdy</surname><given-names>HA</given-names></name></person-group><article-title>Therapeutic drug monitoring of six contraindicated/co-administered drugs by simple and green RP-HPLC-PDA; application to spiked human plasma</article-title><source>BMC Chem</source><year>2024</year><volume>18</volume><fpage>66</fpage><pub-id pub-id-type="doi">10.1186/s13065-024-01161-y</pub-id><pub-id pub-id-type="pmid">38581021</pub-id>
</element-citation><mixed-citation id="mc-CR40" publication-type="journal">Hesham N, Hegazy MA, Wagdy HA. Therapeutic drug monitoring of six contraindicated/co-administered drugs by simple and green RP-HPLC-PDA; application to spiked human plasma. BMC Chem. 2024;18:66.<pub-id pub-id-type="pmid">38581021</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name><surname>Ibrahim</surname><given-names>MM</given-names></name><name><surname>Kelani</surname><given-names>KM</given-names></name><name><surname>Ramadan</surname><given-names>NK</given-names></name><name><surname>Elzanfaly</surname><given-names>ES</given-names></name><name><surname>Saad</surname><given-names>AS</given-names></name></person-group><article-title>Solid contact potentiometric sensor for the assay of loperamide hydrochloride in its pharmaceutical formulation and spiked plasma samples</article-title><source>Anal Bioanal Electrochem.</source><year>2022</year><volume>14</volume><fpage>904</fpage></element-citation><mixed-citation id="mc-CR41" publication-type="journal">Ibrahim MM, Kelani KM, Ramadan NK, Elzanfaly ES, Saad AS. Solid contact potentiometric sensor for the assay of loperamide hydrochloride in its pharmaceutical formulation and spiked plasma samples. Anal Bioanal Electrochem. 2022;14:904.</mixed-citation></citation-alternatives></ref></ref-list></back></article>